January 18, 2023
The FDA has approved another Tdap vaccine option for use during pregnancy to prevent pertussis, otherwise known as whooping cough.
Previously hepatitis B vaccines have offered lower levels of protection for people living with HIV. New research indicates that a 3-dose series could offer much better protection.
January 17, 2023
The updates include new recommendations for COVID-19 and pneumococcal vaccines.
Childhood vaccinations took a downturn during the pandemic. Now is the time to get them done and pharmacists can help.
January 16, 2023
In the 3 cases documented by researchers, hepatitis B surface antigen (HBsAG) levels were reduced by more than 50% after Japan began its COVID-19 vaccination program.
January 13, 2023
A trio of leading hepatitis researchers survey the treatments in development for chronic hepatitis B. They end on a high note: That for the first time in 20 years, a cure is in sight.
Earlier results suggesting that fluvoxamine might be an effective treatment were from trials conducted earlier in the pandemic when vaccines weren’t available and other variants were circulating.
October 26, 2022
October 22, 2022
Results of multiple studies were presented at IDWeek 2022.
After multiple approvals and emergency use authorizations, It’s time to take stock of the state of pediatric COVID-19 vaccines.
